Literature DB >> 29679680

NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.

Roger L Papke1, Can Peng2, Ashok Kumar3, Clare Stokes2.   

Abstract

Long-term potentiation (LTP) in the dentate gyrus was previously shown to be enhanced by nicotine, an effect dependent on both homomeric α7 and heteromeric α2β2 nicotinic acetylcholine receptors (nAChR). In our experiments, bath-applied nicotine produced no significant enhancement of LTP. The α7 nAChR silent agonist NS6740, a weak activator of α7 nAChR ion channels but an effective modulator of the cholinergic anti-inflammatory pathway, decreased LTP and, additionally, produced a substantial reduction in the baseline synaptic function prior to the high frequency stimulation used to induce LTP. The effects of NS6740 on the various ligand-gated ion channels associated with the generation and modulation of dentate LTP were evaluated with receptors expressed in Xenopus oocytes. A 60 s pre-application of 5 μM NS6740 to α7 receptors blocked the response to subsequent applications of acetylcholine (ACh). In contrast, the responses of α2β2 nAChR to control applications of ACh were not significantly affected by NS6740. Likewise, responses of cells expressing GluR1 + GluR2 AMPA-type glutamate receptor subunits or GABAA α1, β2, and γ2L subunits to control agonist applications (100 μM kainic acid or 10 μM GABA, respectively), were unaffected by NS6740. The effects of NS6740 on α7 were inconsistent with simple antagonism since, while unresponsive to ACh, the receptors exposed to NS6740 were effectively activated by the positive allosteric modulator PNU-120596. The results support the hypothesis that NS6740 switches the mode of α7 signaling in a channel-independent manner that can reduce synaptic function.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Dentate gyrus; Hippocampus; LTP; NS6740; Nicotinic acetylcholine receptors; PNU-120596; α7 Signaling

Mesh:

Substances:

Year:  2018        PMID: 29679680      PMCID: PMC6191859          DOI: 10.1016/j.neulet.2018.04.025

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  63 in total

Review 1.  Cholinergic control of inflammation.

Authors:  M Rosas-Ballina; K J Tracey
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.

Authors:  Matthijs Kox; Jeroen F van Velzen; Jan C Pompe; Cornelia W Hoedemaekers; Johannes G van der Hoeven; Peter Pickkers
Journal:  Biochem Pharmacol       Date:  2009-07-01       Impact factor: 5.858

3.  Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease.

Authors:  R Azuma; M Komuro; B H Korsch; J C Andre; O Onnagawa; S R Black; J M Mathews
Journal:  Xenobiotica       Date:  1999-07       Impact factor: 1.908

4.  Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis.

Authors:  A Bruchfeld; R S Goldstein; S Chavan; N B Patel; M Rosas-Ballina; N Kohn; A R Qureshi; K J Tracey
Journal:  J Intern Med       Date:  2010-02-18       Impact factor: 8.989

5.  Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents.

Authors:  Rick L Pieschl; Regina Miller; Kelli M Jones; Debra J Post-Munson; Ping Chen; Kimberly Newberry; Yulia Benitex; Thaddeus Molski; Daniel Morgan; Ivar M McDonald; John E Macor; Richard E Olson; Yukiko Asaka; Siva Digavalli; Amy Easton; James Herrington; Ryan S Westphal; Nicholas J Lodge; Robert Zaczek; Linda J Bristow; Yu-Wen Li
Journal:  Eur J Pharmacol       Date:  2017-04-22       Impact factor: 4.432

6.  The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.

Authors:  Roger L Papke; Nicole A Horenstein; Abhijit R Kulkarni; Clare Stokes; Lu W Corrie; Cheol-Young Maeng; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

7.  The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.

Authors:  Morten S Thomsen; Jens D Mikkelsen
Journal:  J Neuroimmunol       Date:  2012-08-09       Impact factor: 3.478

8.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

Review 9.  New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.

Authors:  Deniz Bagdas; Mine S Gurun; Pamela Flood; Roger L Papke; M Imad Damaj
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

10.  Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome.

Authors:  Matthew J Mulcahy; Sydney B Blattman; Francisco J Barrantes; Ronald J Lukas; Edward Hawrot
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

View more
  6 in total

1.  H/D Exchange Characterization of Silent Coupling: Entropy-Enthalpy Compensation in Allostery.

Authors:  Charulata B Prasannan; Aleksandra Gmyrek; Tyler A Martin; Maria T Villar; Antonio Artigues; James Ching Lee; Aron W Fenton
Journal:  Biophys J       Date:  2020-05-20       Impact factor: 4.033

2.  Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test.

Authors:  Asti Jackson; Y Alkhlaif; R L Papke; D H Brunzell; M I Damaj
Journal:  Psychopharmacology (Berl)       Date:  2019-07-13       Impact factor: 4.530

Review 3.  α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity.

Authors:  Ayland C Letsinger; Zhenglin Gu; Jerrel L Yakel
Journal:  Trends Neurosci       Date:  2021-12-13       Impact factor: 13.837

4.  Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site.

Authors:  Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Clelia Dallanoce; Ganesh A Thakur; Roger L Papke
Journal:  Eur J Pharmacol       Date:  2021-05-15       Impact factor: 5.195

Review 5.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

6.  Bibliometric analysis of nicotinic acetylcholine receptors channel research (2000-2020).

Authors:  Xueping Zhu; Yan Zhou; Guozhen Yuan; Jingjing Shi; Shuai Shi; Limei Zhang; Ruoning Chai; Yihang Du; Chenglin Duan; Yuanhui Hu
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.